| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.189.975 |
| Chemical and physical data | |
| Formula | C15H17N3O2 |
| Molar mass | 271.320 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
PHA-543,613 is a drug that acts as a potent and selectiveagonist for theα7 subtype of neuralnicotinic acetylcholine receptors, with a high level of brain penetration and good oral bioavailability. It is under development as a possible treatment for cognitive deficits inschizophrenia.[1] It reducesexcitotoxicity[2] and protects striatal dopaminergic neurons in rat models.[3] It also potentiates cognitive enhancement frommemantine,[4][5] decreases dynorphin release[6] and inhibits GSK-B3.[7]